Correlation Between Bank Central and Nu-Med Plus

Can any of the company-specific risk be diversified away by investing in both Bank Central and Nu-Med Plus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Nu-Med Plus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank Central Asia and Nu Med Plus, you can compare the effects of market volatilities on Bank Central and Nu-Med Plus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Nu-Med Plus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Nu-Med Plus.

Diversification Opportunities for Bank Central and Nu-Med Plus

0.4

Correlation Coefficient

Bank Central  Nu-Med Plus

Very weak diversification

The 3 months correlation between Bank and Nu-Med is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Nu Med Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nu Med Plus and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Nu-Med Plus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nu Med Plus has no effect on the direction of Bank Central i.e., Bank Central and Nu-Med Plus go up and down completely randomly.

Pair Corralation between Bank Central and Nu-Med Plus

Assuming the 90 days horizon Bank Central Asia is expected to under-perform the Nu-Med Plus. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bank Central Asia is 7.22 times less risky than Nu-Med Plus. The pink sheet trades about -0.15 of its potential returns per unit of risk. The Nu Med Plus is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1.26  in Nu Med Plus on December 20, 2024 and sell it today you would lose (0.45) from holding Nu Med Plus or give up 35.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.72%
Values	Daily Returns

Bank Central Asia  vs.  Nu Med Plus

Bank Central Asia

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nu Med Plus

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nu Med Plus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather conflicting primary indicators, Nu-Med Plus may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Bank Central and Nu-Med Plus

The main advantage of trading using opposite Bank Central and Nu-Med Plus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Nu-Med Plus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nu-Med Plus will offset losses from the drop in Nu-Med Plus' long position.

The idea behind Bank Central Asia and Nu Med Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.